PAHC — Phibro Animal Health Cashflow Statement
0.000.00%
Last trade - 00:00- $728.66m
- $1.41bn
- $1.02bn
- 88
- 51
- 90
- 91
Annual cashflow statement for Phibro Animal Health, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 33.6 | 54.4 | 49.2 | 32.6 | 2.42 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -1.01 | -5.91 | -4.79 | -9.34 | 27.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -13.7 | -29.9 | -44.6 | -41.1 | 33.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 59.3 | 48.3 | 31.6 | 13.3 | 87.6 |
| Capital Expenditures | -34 | -29.3 | -37 | -51.8 | -41.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -86.3 | 10.7 | 14.5 | -22.2 | -6.96 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -120 | -18.6 | -22.6 | -74 | -48.2 |
| Financing Cash Flow Items | — | -2.94 | -4.84 | 3.74 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 40.9 | -17 | 16.3 | 27 | -6.77 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -21.2 | 13.9 | 24 | -33 | 29.3 |